Pharmadrug (PHRX) Stock Statistics & Valuation Metrics

Pharmadrug has a market cap or net worth of C$1.62M. The enterprise value is C$2.62M.

Pharmadrug has 108,234,380 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmadrug’s return on equity (ROE) is 0.57 and return on invested capital (ROIC) is -639.06%.

The current PE Ratio of Pharmadrug is ―. Pharmadrug’s PEG ratio is 0.01.

In the last 12 months, Pharmadrug had revenue of 0.00 and earned -793.27K in profits. Earnings per share was -0.01.

In the last 12 months, operating cash flow was -80.90K and capital expenditures 5.00, giving a free cash flow of -80.90K billion.

Pharmadrug pays an annual dividend of ―, resulting in a dividend yield of ―

Pharmadrug upcoming earnings date is May 6, 2026, TBA (Confirmed).

Pharmadrug as a current ratio of 0.08, with Debt / Equity ratio of -92.38%

In the past 12 months, Pharmadrug has paid 0.00 in taxes.

Pharmadrug EV to EBITDA ratio is -4.21, with an EV/FCF ratio of -3.01.

Pharmadrug has C$17.72K in cash and marketable securities with C$1.43M in debt, giving a net cash position of -C$1.42M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Pharmadrug is ―, which is 11.43% higher than the current price. The consensus rating is ―